Daniele Rossini Selected Research

Daniele Rossini Research Topics

Disease

49	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 01/2015
16	Neoplasms (Cancer) 11/2023 - 01/2013
8	Disease Progression 01/2023 - 01/2018
6	Neoplasm Metastasis (Metastasis) 09/2023 - 10/2015
5	Neutropenia 01/2023 - 01/2015
2	Hypertension (High Blood Pressure) 12/2022 - 02/2022
2	Diarrhea 12/2022 - 08/2020
2	Febrile Neutropenia 01/2022 - 08/2020
1	Triple Negative Breast Neoplasms 01/2023
1	Rectal Neoplasms (Rectal Cancer) 01/2023
1	Neoplasm Micrometastasis 01/2023
1	Myocardial Infarction 01/2022
1	Obesity 01/2022
1	Microsatellite Instability 01/2021
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 02/2020
1	Sarcoma (Soft Tissue Sarcoma) 01/2020
1	Adenocarcinoma 01/2019
1	Infarction (Infarctions) 01/2018
1	Necrosis 01/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 08/2017
1	Carcinoma (Carcinomatosis) 01/2017
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2017

Drug/Important Bio-Agent (IBA)

21	Bevacizumab (Avastin)FDA Link 11/2023 - 02/2015
9	Irinotecan (Camptosar)FDA LinkGeneric 09/2023 - 01/2018
8	ErbB Receptors (EGF Receptor)IBA 04/2024 - 01/2016
8	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2023 - 01/2018
8	Fluorouracil (Carac)FDA LinkGeneric 12/2023 - 01/2018
7	Biomarkers (Surrogate Marker)IBA 02/2022 - 08/2017
6	Leucovorin (Folinic Acid)FDA Link 12/2023 - 01/2018
6	Panitumumab (Vectibix)FDA Link 12/2023 - 01/2018
5	Cetuximab (Erbitux)FDA Link 09/2023 - 01/2018
5	Monoclonal AntibodiesIBA 01/2023 - 10/2015
4	regorafenibIBA 10/2023 - 10/2020
4	trifluridine tipiracil drug combinationIBA 10/2023 - 01/2015
4	atezolizumabIBA 01/2023 - 07/2020
4	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2021
3	Calcibiotic Root Canal SealerIBA 01/2022 - 01/2016
2	Circulating Tumor DNAIBA 04/2024 - 01/2023
2	Epidermal Growth Factor (EGF)IBA 01/2021 - 12/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2020 - 08/2017
2	AntibodiesIBA 01/2020 - 01/2016
1	Messenger RNA (mRNA)IBA 10/2023
1	encorafenibIBA 09/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Trinitrotoluene (TNT)IBA 01/2023
1	Sorafenib (BAY 43-9006)FDA Link 12/2022
1	SaltsIBA 01/2022
1	PlatinumIBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	Angiopoietin-2IBA 01/2022
1	avelumabIBA 10/2021
1	Tyrosine Kinase InhibitorsIBA 10/2020
1	afliberceptIBA 05/2020
1	Capecitabine (Xeloda)FDA Link 01/2020
1	Exonucleases (3' 5' Exonuclease)IBA 12/2019
1	Codon (Codons)IBA 12/2019
1	Cytotoxins (Cytolysins)IBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Angiopoietin-like ProteinsIBA 08/2017
1	Transcription Factors (Transcription Factor)IBA 08/2017
1	LigandsIBA 08/2017
1	Interleukin-8 (Interleukin 8)IBA 08/2017
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2017
1	Fibrinogen (Factor I)FDA Link 02/2015
1	Lactate DehydrogenasesIBA 02/2015

Therapy/Procedure

19	Therapeutics 11/2023 - 02/2015
16	Drug Therapy (Chemotherapy) 12/2023 - 01/2013
3	Radiotherapy 01/2023 - 01/2013
2	Retreatment 01/2023 - 01/2020
1	Hepatectomy 09/2023
1	Consolidation Chemotherapy 01/2023
1	Adjuvant Chemotherapy 01/2023
1	Neoadjuvant Therapy 01/2023